Center for Evidence-Based Chinese Medicine, Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Front Public Health. 2022 Jun 9;10:895552. doi: 10.3389/fpubh.2022.895552. eCollection 2022.
OBJECTIVE: Multicriteria decision analysis (MCDA) is a useful tool in complex decision-making situations, and has been used in medical fields to evaluate treatment options and drug selection. This study aims to provide valuable insights into MCDA in healthcare through examining the research focus of existing studies, major fields, major applications, most productive authors and countries, and most common journals in the domain. METHODS: A bibliometric analysis was conducted on the publication related to MCDA in healthcare from the Web of Science Core Collection (WoSCC) database on 14 July 2021. Three bibliometric software (VOSviewer, R-bibliometrix, and CiteSpace) were used to conduct the analysis including years, countries, institutes, authors, journals, co-citation references, and keywords. RESULTS: A total of 410 publications were identified with an average yearly growth rate of 32% (1999-2021), from 196 academic journals with 23,637 co-citation references by 871 institutions from 70 countries/regions. The United States was the most productive country ( = 80). Universiti Pendidikan Sultan Idris ( = 16), Université de Montréal ( = 13), and Syreon Research Institute ( = 12) were the top productive institutions. A A Zaidan, Mireille Goetghebeur and Zoltan Kalo were the biggest nodes in every cluster of authors' networks. The top journals in terms of the number of articles ( = 17) and citations ( = 1,673) were and , respectively. The extant literature has focused on four aspects, including the analytic hierarchy process (AHP), decision-making, health technology assessment, and healthcare waste management. COVID-19 and fuzzy TOPSIS received careful attention from MCDA applications recently. MCDA in big data, telemedicine, TOPSIS, and fuzzy AHP is well-developed and an important theme, which may be the trend in future research. CONCLUSION: This study uncovers a holistic picture of the performance of MCDA-related literature published in healthcare. MCDA has a broad application on different topics and would be helpful for practitioners, researchers, and decision-makers working in healthcare to advance the wheel of medical complex decision-making. It can be argued that the door is still open for improving the role of MCDA in healthcare, whether in its methodology (e.g., fuzzy TOPSIS) or application (e.g., telemedicine).
目的:多准则决策分析(MCDA)是一种在复杂决策情况下有用的工具,并已在医学领域用于评估治疗方案和药物选择。本研究旨在通过研究现有研究的研究重点、主要领域、主要应用、最有成效的作者和国家以及该领域最常见的期刊,为医疗保健中的 MCDA 提供有价值的见解。
方法:于 2021 年 7 月 14 日,在 Web of Science 核心合集(WoSCC)数据库中对与医疗保健中的 MCDA 相关的出版物进行了文献计量分析。使用三种文献计量软件(VOSviewer、R-bibliometrix 和 CiteSpace)进行分析,包括年份、国家、机构、作者、期刊、共引参考文献和关键词。
结果:共确定了 410 篇出版物,其平均年增长率为 32%(1999-2021 年),来自 196 种学术期刊,引用了 23637 次,涉及 70 个国家/地区的 871 个机构。美国是最具生产力的国家(=80)。Universiti Pendidikan Sultan Idris(=16)、Université de Montréal(=13)和 Syreon Research Institute(=12)是最具生产力的机构。A A Zaidan、Mireille Goetghebeur 和 Zoltan Kalo 是作者网络每个聚类中最大的节点。就文章数量(=17)和引文数量(=1673)而言,排名最高的期刊分别为 和 。最近,COVID-19 和模糊 TOPSIS 受到了 MCDA 应用的关注。MCDA 在医疗保健中的层次分析法(AHP)、决策、卫生技术评估和医疗废物管理等方面的应用已经得到了广泛关注。大数据、远程医疗、TOPSIS 和模糊 AHP 中的 MCDA 发展良好,是一个重要的主题,可能是未来研究的趋势。
结论:本研究揭示了医疗保健中 MCDA 相关文献的整体表现。MCDA 在不同主题上有广泛的应用,有助于医疗保健领域的从业者、研究人员和决策者推动医学复杂决策的车轮。可以说,无论在方法(例如模糊 TOPSIS)还是应用(例如远程医疗)方面,MCDA 在医疗保健中的作用都有改进的空间。
Front Public Health. 2022
J Cardiothorac Surg. 2024-5-11
Front Public Health. 2022
J Control Release. 2022-5
Front Public Health. 2022
Front Biosci (Landmark Ed). 2022-8-31
Appl Health Econ Health Policy. 2025-7
Front Aging Neurosci. 2024-11-27
Healthcare (Basel). 2024-9-14
Front Neurosci. 2023-2-6
Front Cardiovasc Med. 2022-10-20
Int J Intell Syst. 2021-6
Hum Vaccin Immunother. 2022-12-31
Animals (Basel). 2021-11-26
Int J Environ Res Public Health. 2021-5-14
Waste Manag Res. 2021-6
Hum Vaccin Immunother. 2021-3-4